申请人:BASF Aktiensellschaft
公开号:US04922021A1
公开(公告)日:1990-05-01
The invention is directed to 1-(2,6-Dimethyl-Phenyl-amino)-2-Dimethyl-amino-Propane and the pharmaceutical composition thereof useful for the treatment of cardiac rhythm disorders.
该发明涉及1-(2,6-二甲基苯基氨基)-2-二甲基氨基丙烷及其药物组合物,用于治疗心脏节律紊乱。